Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Metastatic Non-Clear Cell Renal Cell Carcinoma
NCT01538238Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- May 2012
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in non-clear cell renal cell carcinoma (nccRCC), sponsored by Samsung Medical Center. Started May 2012; status: completed.
02
Drugs
pazopanib
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on NCT01538238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538238.